LAUSANNE, Switzerland--(BUSINESS WIRE)--Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results